AstraZeneca (AZN) RNS Announcements

Add to Alert list
Date Time Source Announcement
25 May 2012 07:00 AM
RNS
Transaction in Own Shares
24 May 2012 07:00 AM
RNS
Transaction in Own Shares
21 May 2012 07:00 AM
RNS
Transaction in Own Shares
18 May 2012 07:00 AM
RNS
Transaction in Own Shares
17 May 2012 07:00 AM
RNS
Transaction in Own Shares
16 May 2012 07:00 AM
RNS
Transaction in Own Shares
15 May 2012 07:00 AM
RNS
Transaction in Own Shares
14 May 2012 07:00 AM
RNS
Transaction in Own Shares
11 May 2012 07:00 AM
RNS
Transaction in Own Shares
10 May 2012 07:00 AM
RNS
Transaction in Own Shares
09 May 2012 07:00 AM
RNS
Transaction in Own Shares
08 May 2012 07:00 AM
RNS
Transaction in Own Shares
04 May 2012 07:00 AM
RNS
Transaction in Own Shares
03 May 2012 07:00 AM
RNS
Transaction in Own Shares
02 May 2012 07:00 AM
RNS
Transaction in Own Shares
01 May 2012 04:00 PM
RNS
Total Voting Rights
01 May 2012 07:00 AM
RNS
Transaction in Own Shares
30 Apr 2012 07:00 AM
RNS
Transaction in Own Shares
27 Apr 2012 04:30 PM
RNS
Director/PDMR Shareholding
27 Apr 2012 07:00 AM
RNS
Transaction in Own Shares
26 Apr 2012 06:09 PM
RNS
Result of AGM
26 Apr 2012 07:05 AM
RNS
Transaction in Own Shares
26 Apr 2012 07:03 AM
RNS
David Brennan to retire as CEO 1 June 2012
26 Apr 2012 07:00 AM
RNS
1st Quarter Results
25 Apr 2012 09:00 AM
RNS
Notice of Results
25 Apr 2012 07:00 AM
RNS
Transaction in Own Shares
24 Apr 2012 07:00 AM
RNS
Transaction in Own Shares
23 Apr 2012 07:00 AM
RNS
Acquires Ardea Biosciences for $1 billion
23 Apr 2012 07:00 AM
RNS
Transaction in Own Shares
20 Apr 2012 02:17 PM
RNS
FORXIGA gets positive CHMP opinion in the EU
20 Apr 2012 07:00 AM
RNS
Transaction in Own Shares
19 Apr 2012 07:00 AM
RNS
Transaction in Own Shares
18 Apr 2012 07:00 AM
RNS
Transaction in Own Shares
17 Apr 2012 07:00 AM
RNS
Transaction in Own Shares
16 Apr 2012 07:00 AM
RNS
Transaction in Own Shares
13 Apr 2012 07:00 AM
RNS
Transaction in Own Shares
12 Apr 2012 07:00 AM
RNS
Transaction in Own Shares
11 Apr 2012 04:30 PM
RNS
Annual Information Update
11 Apr 2012 07:00 AM
RNS
Transaction in Own Shares
10 Apr 2012 07:00 AM
RNS
Transaction in Own Shares
05 Apr 2012 07:00 AM
RNS
Transaction in Own Shares
04 Apr 2012 07:00 AM
RNS
Transaction in Own Shares
03 Apr 2012 07:00 AM
RNS
Partners Amgen to develop inflammation portfolio
03 Apr 2012 07:00 AM
RNS
Transaction in Own Shares
02 Apr 2012 04:00 PM
RNS
Director/PDMR Shareholding
02 Apr 2012 04:00 PM
RNS
Director/PDMR Shareholding
02 Apr 2012 04:00 PM
RNS
Director/PDMR Shareholding
02 Apr 2012 04:00 PM
RNS
Director/PDMR Shareholding
02 Apr 2012 03:30 PM
RNS
Total Voting Rights
02 Apr 2012 07:00 AM
RNS
Transaction in Own Shares

AstraZeneca plc is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England.

It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation. It was involved in developing the Oxford–AstraZeneca COVID-19 vaccine.

Astra Zeneca share price launched at 605p in 1993.

UK 100

Latest directors dealings